4
Total investments
1
Early stage
0
Mid stage
0
Late stage
8y
Years active
Portfolio
1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Experience · 7 entries
All (7)
Investments (4)
Board (2)
2020
Biotech Analyst, Public & Private Investor
Jun 2020
PFM Health Sciences is a San Francisco-based Healthcare investment manager.
2019
A
Acrivon Therapeutics
Board Observer
2019
2018
Principal, Biotech Venture Capital Investor
May 2018
New Enterprise Associates, Inc. (NEA) is a global venture capital firm focused on helping entrepreneurs build transformational businesses across multiple stages, sectors and geographies. Founded in 1977, NEA has more than $28 billion in assets under management as of June 30, 2025 and invests in technology and healthcare companies at all stages in a company’s lifecycle, from seed stage through IPO. The firms long track record of investing includes 284 portfolio company IPOs and more than 500 mergers and acquisitions. For more information, please visit www.nea.com.
2016
Vice President, Biotech Equity Research
Mar 2016
As a leading corporate and investment bank, TD Securities offers a wide range of integrated capital markets products and services. Our corporate, government, and institutional clients choose us for our innovation, execution, and experience.
With more than 6,500 professionals operating out of 40 cities across the globe, we help our clients meet their needs today and prepare for tomorrow. Our services include underwriting and distributing new issues, providing trusted advice and industry-leading insight, extending access to global markets, and delivering integrated transaction banking solutions.
We are growth-oriented, people-focused, and community-minded. As an integrated team, we work to deliver value for our clients every day.
Terms of Use - bit.ly/2IHjg1N
Protect yourself from recruitment fraud - bit.ly/3ySZHwj
Show all 7 entries ↓
Investment activity
2018–2020 · 4 investments
Recent (last 2 years)Earlier